Hermaphroditism pathology;Pathologie des hermaphrodismes

Annales de Pathologie

Volumn 24, Issue 6, 2004, Pages 499-509

  Jaubert, Francis ^a   Nihoul Fékété, Claire ^a   Lortat Jacob, Stephen ^a   Josso, Nathalie ^b   Fellous, Marc ^c  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c Hôpital Cochin ^*  (France)

Author keywords

Adenoma; Androgen receptor; Dysgerminoma; Gonadal dysgenesis; Gonadoblastoma; Hermaphroditism; Leiomyoma

Indexed keywords

STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ADRENAL TUMOR; ANDROGEN INSENSITIVITY SYNDROME; DRASH SYNDROME; DYSGERMINOMA; FEMALE; FRASIER SYNDROME; GENITAL MALFORMATION; GENITAL SYSTEM DISEASE; GENOTYPE PHENOTYPE CORRELATION; GONADAL DYSGENESIS; GONADOBLASTOMA; HERMAPHRODITISM; HORMONE DEFICIENCY; HUMAN; LEYDIG CELL TUMOR; MALE; MIXED TUMOR; PERSISTENT MULLERIAN DUCT SYNDROME; REVIEW; SEX CORD TUMOR; SEX DIFFERENTIATION; SEX TRANSFORMATION; SEXUAL DEVELOPMENT; STEROID 5ALPHA REDUCTASE 2 DEFICIENCY; SYNDROME; TESTOSTERONE SYNTHESIS; TRUE HERMAPHRODITISM; TURNER SYNDROME; XX MALE;

EID: 14244259217     PISSN: 02426498     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0242-6498(04)94014-x     Document Type: Review

References (42)

1. Rutgers JL, Scully R.E. Pathology of the testis in intersex syndromes. Semin Diagn Pathol 1987; 4: 275-91.
2. Morel Y, Rey R, Teinturier C, Nicolino M, Michel-Calemard L, Mowszowicz I et al. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 2002; 161: 49-59.
3. Lee MM, Donahoe PK. Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 1993; 14: 152-64.
4. Rutgers JL, Scully RE. The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol 1991; 10: 126-44.
5. Griffin JE. Androgen resistance - The clinical and molecular spectrum. N Engl J Med 1992; 326: 611-8.
6. Quigley CA, de Bellis A, Marschke KB, El-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical and molecular perspectives. Endocr Rev 1995; 16: 271-321.
7. Damiani D, Mascolli M, Almeida MJ, Jaubert F, Fellous M, Dichtchekenian V et al. Persistence of Mullerian remnants in complete androgen insensitivity syndrome. J Pediatr Endocrinol Metab 2003; 15: 1553-6.
8. Wilson JD, Griffin JE, Russell DW. Steroid 5α-reductase 2 deficiency. Endocr Rev 1993; 14: 577-93.
9. Rodien P, Mebarki F, Mowszowicz I, Chaussain JL, Young J, Morel Y et al. Different phenotypes in a family with androgen insensitivity caused by the same M7801 point mutation in the androgen receptor gene. J Clin Endocrinol Metab 1996; 81: 2994-8.
10. Belville C, Josso N, Picard JY. Persistence of mullerian derivatives in males. Am J Med Genet 1999; 89: 218-23.
11. Boucekkine C, Toublanc JE, Abbas N, Chaabouni S, Ouahid S, Semrouni M et al. Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA-sequences. Clin Endocrinol 1994; 40: 733-42.
12. Salas-Cortes L, Jaubert F, Barbaux S, Nessmann C, Bono MR, Fellous M et al. The human SRY protein is present in fetal and adult Sertoli cells and germ cells. Int J Dev Biol 1999; 43: 135-40.
13. Salas-Cortes L, Jaubert F, Bono MR, Fellous M, Rosemblatt M. Expression of the human SRY protein during development in normal male gonadal and sex-reversed tissues. J Exp Zool 2001; 290: 607-15.
14. Cotinot C, Pailhoux E, Jaubert F, Fellous M. Molecular genetics of sex determination. Semin Reprod Med 2002; 20: 157-68.
15. Gravholt CH, Fedder J, Naeraa RW, Muller J. Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 2000; 85: 3199-202.
16. Vilain E, McElreavey K, Jaubert F, Raymond JP, Richaud F, Fellous M. Familial case with sequence variant in the testis-determining region associated with two sex phenotypes. Am J Hum Genet 1992; 50: 1008-11.
17. Abbas N, McElreavey K, Leconiat M, Vilain E, Jaubert F, Berger R et al. Familial case of 46,XX male and 46,XX true hermaphrodite associated with a paternal-derived SRY-bearing X chromosome. CR Acad Sci III 1993; 316: 375-83.
18. Vilain E, Le Fiblec B, Morichon-Delvallez N, Brauner R, Dommergues M, Dumez Y et al. SRY-negative XX fetus with complete male phenotype. Lancet 1994; 343: 240-1.
19. McElreavey KD, Vilain E, Boucekkine C, Vidaud M, Jaubert F, Richaud F et al. XY sex reversal associated with a nonsense mutation in SRY. Genomics 1992; 13: 838-40.
20. Hadjiathanasiou CG, Brauner R, Lortat-Jacob S, Nivot S, Jaubert F, Fellous M et al. True hermaphroditism: genetic variants and clinical management. J Pediatr 1994; 125: 738-44.
21. Salas-Cortes L, Jaubert F, Nihoul-Fékété C, Brauner R, Rosemblatt M, Fellous M. SRY protein is expressed in ovotestis and streak gonads from human sex-reversal. Cytogenet Cell Genet 2000; 91: 212-6.
22. Robboy SJ, Miller T, Donahoe PK, Jahre C, Welch WR, Haseltine FP et al. Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis: Perspective derived from a clinicopathologic analysis of twenty-one cases. Hum Pathol 1982; 13: 700-16.
23. Berkovitz GD, Fechner PY, Zacur HW, Rock JA, Snyder HM 3rd, Migeon CJ et al. Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: its relevance to the understanding of sex differentiation. Medicine 1991; 70: 375-83.
24. Mendez JP, Ulloa-Aguirre A, Kofman-Alfaro S, Mutchinick O, Fernandez-del-Castillo C, Reyes E et al. Mixed gonadal dysgenesis: clinical, cytogenetic, endocrinological, and histopathological findings in 16 patients. Am J Med Genet 1993; 46: 263-7.
25. Rey R, al-Attar L, Louis F, Jaubert F, Barbet P, Nihoul- Fékété C et al. Testicular dysgenesis does not affect expression of anti-mullerian hormone by Sertoli cells in premeiotic seminiferous tubules. Am J Pathol 1996; 148: 1689-98.
26. Manivel JC, Sibley RK, Dehner LP. Complete and incomplete Drash syndrome: a clinicopathologic study of five cases of a dysontogenetic-neoplastic complex. Hum Pathol 1987; 18: 80-9.
27. Auber F, Lortat-Jacob S, Sarnacki S, Jaubert F, Salomon R, Thibaud E et al. Surgical management and genotype/phenotype correlations in WT1 gene-related diseases (Drash, Frasier syndromes). J Pediatr Surg 2003; 38: 124-9.
28. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet 1997; 17: 467-70.
29. Barbosa AS, Hadjiathanasiou CG, Theodoridis C, Papathanasiou A, Tar A, Merksz M et al. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Hum Mutat 1999; 13: 146-53.
30. Lau YFC. Sex chromosome genetics '99: Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet 1999; 64: 921-7.
31. Verp MS, Simpson JL. Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 1987; 25: 191-218.
32. Manivel JC, Jessurun J, Wick MR, Dehner LP. Placental alkaline phosphatase immunoreactivity in testicular germ-cell neoplasms. Am J Surg Pathol 1987; 11: 21-9.
33. Jorgensen N, Müller J, Jaubert F, Clausen OP, Skakkebaek NE. Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology 1997; 30: 177-86.
34. Soosay GN, Bobrow L, Happerfield L, Parkinson MC. Morphology and immunohistochemistry of carcinoma in situ adjacent to testicular germ cell tumours in adults and children: implications for histogenesis. Histopathology 1991; 19: 537-44.
35. Hawkins E, Heifetz SA, Giller R, Cushing B. The prepubertal testis (prenatal and postnatal): its relationship to intratubular germ cell neoplasia: a combined Pediatric Oncology Group and Children's Cancer Study Group. Hum Pathol 1997; 28: 404-10.
36. Safneck JR, deSa DJ. Structures mimicking sex cord-stromal tumours and gonadoblastomas in the ovaries of normal infants and children. Histopathology 1986; 10: 909-20.
37. Manivel JC, Dehner LP, Burke B. Ovarian tumorlike structures, biovular follicles, and binucleated oocytes in children: their frequency and possible pathologic significance. Pediatr Pathol 1988; 8: 283-92.
38. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 1999; 341: 1731-6.
39. Rutgers JL, Young RH, Scully RE. The testicular "tumor" of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am J Surg Pathol 1988; 12: 503-13.
40. Meeks JJ, Crawford SE, Russell TA, Morohashi K, Weiss J, Jameson JL. Dax1 regulates testis cord organization during gonadal differentiation. Development 2003; 130: 1029-36.
41. Vialard F, Ottolenghi C, Gonzales M, Choiset A, Girard S, Siffroi JP et al. Deletion of 9p associated with gonadal dysfunction in 46,XY but not in 46,XX human fetuses. J Med Genet 2002; 39: 514-8.
42. Domenice S, Correa RV, Costa EMF, Nishi MY, Vilain E, Arnhold IJP et al. Mutations in the SRY, DAX1, SF1 and WNT4 genes in Brazilian sex-reversed patients. Braz J Med Biol Res 2004; 37: 145-50.